Weighing-Down-America-cover

The costs of obesity

A shocking report.  

"Obesity and excess weight is an expanding health problem for more than 60 percent of Americans, and a new study by Hugh Waters and Ross DeVol finds that it's a tremendous drain on the U.S. economy as well. The total cost to treat health conditions related to obesity—ranging from diabetes to Alzheimer's—plus obesity's drag on attendance and productivity at work exceeds $1.4 trillion annually. That's more than twice what the U.S. spends on national defense. The total, from 2014 data, was equivalent to 8.2 percent of U.S. GDP, and it exceeds the economies of all but three U.S. states and all but 10 countries. The report also highlights how this public health challenge can best be addressed."

Is obesity something that we should be tackling?  My gut (no pun intended) says OMG OF COURSE YES, because we are looking at some very preventable disesases.  Those are some cah-razy numbers.  However, does the pharmaceutical industry care?  I mean:  obesity is Big. Money. 

Read the report:

Weighing-Down-America-cover

http://assets1b.milkeninstitute.org/assets/Publication/ResearchReport/PDF/Weighing-Down-America-WEB.pdf

Smashing records, that’s what we do.

This is totally a press release from the OAC because James writes them so fancy!

3-7-0.

Just wait until next year, guys.

-Beth

OBESITY ACTION COALITION’S 2ND ANNUAL YOUR WEIGHT MATTERS NATIONAL CONVENTION BREAKS ATTENDANCE RECORDS AND EDUCATES AND INVIGORATES MORE THAN 370 INDIVIDUALS SEEKING EVIDENCE-BASED WEIGHT MANAGEMENT STRATEGIES

Tampa, Fla. – More than 370 individuals from 32 states throughout the nation attended the Obesity Action Coalition’s 2nd Annual Your Weight Matters National Convention, Rise to the Challenge, in Phoenix earlier this month. Education, advocacy and support, the core principles of the OAC’s mission, were fully represented during this year’s Convention, tagged “YWM2013” across social media.

The hundreds in attendance were treated to three days of evidence-based information on a variety of topics, such as food addiction, weight bias, self-perception and many more. Led by thought-leaders in the healthcare field, each educational session was presented by one of 37 distinguished experts dedicated to helping individuals gain a better understanding of how their weight impacts their health. In addition to the world-class education, YWM2013 offered attendees a busy Exhibit Hall with 30 exhibitors all showcasing products and services geared toward those affected by excess weight and obesity.

“The education at this year’s Convention was truly unbelievable. As a speaker, I was able to see first-hand how this Convention changed lives. It brought individuals to a new level of awareness. It broke down topics that are often avoided; however, frequently questioned by those affected by the disease of obesity. What makes Convention so special is that it creates a safe and welcoming environment that is free from judgment. In doing so, it allows individuals to feel comfortable and absorb all that Convention has to offer. Being a part of YWM2013 was simply an amazing experience,” said Robert Kushner, MD, Convention Program Agenda Co-Chair.

The OAC is thankful for all those who volunteered their time in both planning YWM2013 and helping onsite. Countless hours were dedicated to ensuring all attendees received an experience like nothing else out there in the way of education and support.

“Last year’s Inaugural Convention in Dallas was amazing. Being in my home state of Texas, it felt surreal to see so many individuals all in one place wanting to learn more about their weight. I honestly thought it was going to be difficult to top the Inaugural Convention; however, YWM2013 did just that – and more. YWM2013 connected people, and when I say ‘connected,’ I am not just talking about attendee-to-attendee. It gave us, the OAC Board of Directors, staff and others, the opportunity to engage with the attendees, learn more about them and their needs, and most of all – help them rise to their own personal challenges,” said Lloyd Stegemann, MD, FASMBS, Convention Program Agenda Co-Chair.

The tremendous success of YWM2013 would not have been possible without the generous support of this year’s sponsors. The OAC would like to thank the 2013 National Sponsors for their generous support: Platinum – Eisai; Gold – Allergan and Vivus, Inc.; Silver – Covidien; Bronze – AmeriWell Bariatrics, Bari Life Bariatric Supplements, Bariatric Advantage, Celebrate Vitamins, Ethicon Endo-Surgery, and Geisinger.

The OAC is excited to announce that the 3rd Annual Your Weight Matters National Convention will take place in Orlando, Fla., at the Renaissance Orlando at Sea World, September 25-28, 2014. Information on next year’s Convention will be located at www.YWMConvention.com

The OAC is a National nonprofit charity dedicated to helping individuals affected by obesity. The OAC was formed to bring together individuals struggling with weight issues and provide educational resources and advocacy tools.

Screen Shot 2013-02-28 at 2.47.00 PM

Lipozene – TO THE RESCUE! NO.

Lipozene sounds like a pharmaceutical drug doesn't it?

Screen Shot 2013-02-28 at 2.47.00 PM

8 weeks = 3.66 lbs weight loss in a study. "Wow."

LIPOZENE!  (What sounds like a…) HARDCORE FAT BURNER TO THE RESCUE!

It's NOT.

But, the commercials, websites and marketing might make you think so.

It is a fiber - glucomannan –

http://en.wikipedia.org/wiki/Lipozene

A health advisory was released by Health Canada stating the following: "natural health products containing the ingredient glucomannan in tablet, capsule or powder form, which are currently on the Canadian market, have a potential for harm if taken without at least 8 ounces of water or other fluid. The risk to Canadians includes choking and/or blockage of the throat, esophagus or intestine, according to international adverse reaction case reports. It is also important to note that these products should NOT be taken immediately before going to bed."[10] The health advisory was issued after authorization of some products containing glucomannan for the purposes of appetite reduction, weight management, treatment of constipation and management of high cholesterol levels

Screen Shot 2013-02-28 at 2.42.22 PM

"Lipozene is made from the Konjac root, most commonly known as >Glucomannan. This water-soluble fiber expands and acts as a dietary fiber gel in your stomach that helps you feel full, so you eat less and as a result, reach your weight loss goals quicker.

 This water-soluble fiber has been cultivated as a weight loss aid in Japan for generations. In fact, there are even studies that connect its main ingredient Glucomannan with alleviating constipation, reducing cholesterol and regulating blood sugar.

 Lipozene is natural and does not contain any stimulants. There are no known harmful side effects when used as directed.

 Lipozene is not a pharmaceutical drug and is available without a prescription.

You should not be taking this "dietary fiber gel" that "expands" inside your stomach if you have had bariatric surgery.

Stop it and talk to your physician.

 

86982-612x612-1

Cleveland Clinic study shows RNY bariatric surgery restores pancreatic function by targeting belly fat

Just to keep you on your toes, a couple days ago I shared the study that stated that WLS doesn't save you money in the long run.

Now, we hear once AGAIN that roux en y gastric bypass bariatric surgery fixes diabetes damn near immediately. This is just another study on THAT topic.

We already knew this.

Thanks, pancreas!  *thumbs up for working so well!*

86982-612x612-1
*Waves to all the post bariatric reactive non-diabetic hypoglycemics*

Visit NBCNews.com for breaking news, world news, and news about the economy

Cleveland Clinic study shows bariatric surgery restores pancreatic function by targeting belly fat

2-year study indicates how gastric bypass reverses diabetes. In a substudy of the STAMPEDE trial (Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently), Cleveland Clinic researchers have found that gastric bypass surgery reverses diabetes by uniquely restoring pancreatic function in moderately obese patients with uncontrolled type 2 diabetes.

546772_10151137586483462_1423053227_n

The FDA’s Assessment of Two Drugs for Chronic Weight Management — NEJM

The FDA's Assessment of Two Drugs for Chronic Weight Management — NEJM.

 

Nejm_colmanp_10-25-2012

 

  • Listen to the podcast above – it's amazingly interesting
  • Qsymia is a combination of phentermine, a sympathomimetic amine
    anorectic, and topiramate extended-release, an antiepileptic drug,
    indicated as an adjunct to a reduced-calorie diet and increased
    physical activity for chronic weight management in adults with an
    initial body mass index (BMI) of:   30 kg/m2 or greater (obese) (1) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes mellitus, or dyslipidemia  

546772_10151137586483462_1423053227_n

You should always consult with your physician before introducing any changes to your diet or level of physical activity.

Indication

Qsymia is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of:

  • 30 kg/m2 or greater (obese) or
  • 27 kg/m2 or greater (overweight) in the presence of at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol

 NEJM - http://www.nejm.org/doi/full/10.1056/NEJMp1211277?query=featured_home